• Although the data are not yet mature,
median PFS in the ITT population was 21.2
months
(21,3 m for ER+ and 20,8m for ER-)
• Across the three taxane subgroups,
median PFS was
19.7
months in the
docetaxel group
,
24.7
months in the paclitaxel group, and
18.1
months in the
nab-paclitaxel group.
PERUSE: Global safety study
Bachelot, SABCS2016
